Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume 54, Issue 9, Pages 1111-1117
Publisher
Informa UK Limited
Online
2019-08-28
DOI
10.1080/00365521.2019.1656773
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies
- (2018) Yan Qiao et al. BMC CANCER
- Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis
- (2018) Yuquan Tao et al. Cancer Management and Research
- Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
- (2018) Tracey G. Simon et al. JAMA Oncology
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer
- (2016) Yin Cao et al. JAMA Oncology
- Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study
- (2015) Maria Rinzivillo et al. NEUROENDOCRINOLOGY
- Exploring the rising incidence of neuroendocrine tumors: A population-based analysis of epidemiology, metastatic presentation, and outcomes
- (2014) Julie Hallet et al. CANCER
- Advanced Digestive Neuroendocrine Tumors
- (2014) Francesco Panzuto et al. PANCREAS
- Aspirin inhibits cell viability and mTOR downstream signaling in gastroenteropancreatic and bronchopulmonary neuroendocrine tumor cells
- (2014) Matilde Spampatti WORLD JOURNAL OF GASTROENTEROLOGY
- Inflammation Amplifier, a New Paradigm in Cancer Biology
- (2013) T. Atsumi et al. CANCER RESEARCH
- The Epidemiology of Neuroendocrine Tumors in Taiwan: A Nation-Wide Cancer Registry-Based Study
- (2013) Hui-Jen Tsai et al. PLoS One
- Aspirin and cancer risk: a quantitative review to 2011
- (2012) C. Bosetti et al. ANNALS OF ONCOLOGY
- Inflammation in Atherosclerosis
- (2012) Peter Libby ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
- (2012) Farhat V.N. Din et al. GASTROENTEROLOGY
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
- (2012) Annemijn M Algra et al. LANCET ONCOLOGY
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimizing the Surgical Effort in Patients With Advanced Neuroendocrine Neoplasm Hepatic Metastases
- (2011) Akshat Saxena et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
- (2010) Farhat V N Din et al. GUT
- Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma
- (2009) Cosimo Durante et al. ENDOCRINE-RELATED CANCER
- Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-Gut
- (2009) Jonathan Strosberg et al. NEUROENDOCRINOLOGY
- Expression Pattern and Functional Relevance of Epidermal Growth Factor Receptor and Cyclooxygenase-2: Novel Chemotherapeutic Targets in Pancreatic Endocrine Tumors?
- (2008) Frank Bergmann et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Neuroendocrine tumor epidemiology
- (2008) Oyvind Hauso et al. CANCER
- NSAIDs and apoptosis
- (2008) N. R. Jana CELLULAR AND MOLECULAR LIFE SCIENCES
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Neuroendocrine tumors of the gastro-entero-pancreatic system
- (2008) Sara Massironi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line
- (2007) Simona Grozinsky-Glasberg et al. NEUROENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now